Skip to main content

Table 1 Baseline characteristics of the study population

From: Predictors of death at home among cancer patients in Israel: a population-based study

Variable Hospital (N = 6479) Home (N = 2635) P value
Age at diagnosis (years) mean ± SD 70.9 ± 13.2 74.0 ± 13.0 < 0.001
Sex (male) Frequency (percent) 3113 (48.0%) 1383 (52.5%) < 0.001
Ethnicity (Jewish) Frequency (percent) 5617 (86.7%) 2378 (90.2%) < 0.001
RSSa mean ± SD 6.0 ± 2.0 6.2 ± 2.0 < 0.001
Education (years) mean ± SD 10.2 ± 4.6 10.7 ± 4.5 < 0.001
Time from cancer diagnosis (months) mean ± SD 23.2 ± 25.5 24.7 ± 26.0 < 0.01
Cancer type
Brain (n = 411) 259 (63.0%) 152 (37.0%)  
Pancreas (n = 666) 427 (64.1%) 239 (35.9%)  
Uterus (n = 490) 124 (64.2%) 69 (35.8%)  
Melanoma (n = 344) 221 (64.2%) 123 (35.8%)  
Prostate (n = 512) 336 (65.6%) 176 (34.4%)  
Colorectal (n = 1352) 802 (66.7%) 450 (33.3%)  
Renal (n = 216) 149 (69.0%) 67 (31.0%)  
Breast (n = 840) 595 (70.8%) 245 (29.2%)  
Ovary (n = 230) 162 (70.4%) 68 (29.6%)  
Stomach (n = 458) 324 (70.7%) 134 (29.3%)  
Lung (n = 1428) 1074 (73.3%) 381 (26.7%)  
Bladder (n = 490) 369 (75.3%) 121 (24.7%)  
Liver (n = 170) 129 (75.9%) 41 (24.1%)  
Lymphoma (n = 316) 252 (79.7%) 64 (20.3%)  
Leukemia (n = 795) 636 (80.0%) 159 (20.0%)  
  1. aRSS Residential Socioeconomic Score